Seeking Alpha

Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline of T – Cell Reprogramming Technologies and Product Candidates Targeting Solid Tumors

Preclinical data demonstrate genetic and epigenetic reprogramming can ameliorate T cell exhaustion and enhance stem-like qualities and potency of T cells in various modalities “Our SITC presentations ...
Seeking Alpha

Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC ...

Five poster presentations to include preclinical data describing new T-cell reprogramming technology being incorporated in LYL119, Lyell’s next product candidate “Our presence at SITC includes ...

Gene linked to beta cell identity loss may explain type 2 diabetes progression

Scientists at City of Hope have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 ...
EurekAlert!

New discovery finds gene converts insulin-producing cells into blood-sugar boosters

Scientists at City of Hope® have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 ...
Diabetes.co.uk

New gene identified in type 2 diabetes progression

Scientists have identified how a gene drives cell dysfunction seen in people with type 2 diabetes, in findings that could ...
University of Geneva

ERC Proof of Concept Grant for Pedro Herrera

Pedro Herrera, full professor in the Department of Genetic Medicine and Development and in the Diabetes Centre at UNIGE Faculty of Medicine, is the winner of an ERC Proof of Concept Grant awarded by ...